Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells
2011 ◽
Vol 82
(11)
◽
pp. 1720-1730
◽
Keyword(s):
2004 ◽
Vol 27
(6)
◽
pp. 781-785
◽
Keyword(s):
2012 ◽
Vol 287
(15)
◽
pp. 11850-11858
◽
Keyword(s):
2006 ◽
Vol 210
(3)
◽
pp. 766-773
◽
2001 ◽
Vol 33
(6)
◽
pp. 2926-2928
◽
Keyword(s):
Keyword(s):